Fetal akinesia: review of the genetics of the neuromuscular causes. Issue 12 (7th October 2011)

• Record Type: Journal Article
• Authors: Ravenscroft, Gianina; Sollis, Elliot; Charles, Adrian K; North, Kathryn N; Baynam, Gareth; Laing, Nigel G
• Is Part Of: Journal of medical genetics. Volume 48:Issue 12(2011)
• Page Start: 793
• Page End: 801
• Publication Date: 2011-10-07
• Subjects: Gene therapy -- genetic screening/counselling -- neuromuscular disease -- molecular genetics -- muscle disease -- neuromuscular disease -- genetics -- paediatric oncology -- genetics; Medical genetics -- Periodicals; 616.042
• DOI: 10.1136/jmedgenet-2011-100211
• Languages: English
• ISSNs: 1468-6244

Abstract

Abstract : Fetal akinesia refers to a broad spectrum of disorders in which the unifying feature is a reduction or lack of fetal movement. Fetal akinesias may be caused by defects at any point along the motor system pathway including the central and peripheral nervous system, the neuromuscular junction and the muscle, as well as by restrictive dermopathy or external restriction of the fetus in utero. The fetal akinesias are clinically and genetically heterogeneous, with causative mutations identified to date in a large number of genes encoding disparate parts of the motor system. However, for most patients, the molecular cause remains unidentified. One reason for this is because the tools are only now becoming available to efficiently and affordably identify mutations in a large panel of disease genes. Next-generation sequencing offers the promise, if sufficient cohorts of patients can be assembled, to identify the majority of the remaining genes on a research basis and facilitate efficient clinical molecular diagnosis. The benefits of identifying the causative mutation(s) for each individual patient or family include accurate genetic counselling and the options of prenatal diagnosis or preimplantation genetic diagnosis. In this review, we summarise known single-gene disorders affecting the spinal cord, peripheral nerves, neuromuscular junction or skeletal muscles that result in fetal akinesia. This audit of these known molecular and pathophysiological mechanisms involved in fetal akinesia provides a basis for improved molecular diagnosis and completing disease gene discovery.